March 1, 2021

India lauds ‘life-saving’ Govt-19 vaccine roll

At the Ernakulam Government General Hospital in Kochi, a drug Govit-19 vaccine is prepared before being given to a drug user.
Image Credit: PTI

NEW DELHI: India’s Govt-19 vaccination campaign has successfully launched, with more than 190,000 people receiving first jabs and no one has been admitted to hospital for major side effects, but there have been reports of concerns about the domestic vaccine.

Authorities have approved emergency use of two vaccines, the Oxford-AstraZeneca and domestic “Kovacin”, which have not yet completed its third phase of testing – and plans to vaccinate about 300 million people in 1.3 billion countries by July.

Leading staff, hospital staff, people over the age of 50 and those who are considered to be at high risk due to pre-existing medical conditions are on the short list to get vaccinated.

“We have received encouraging and satisfactory feedback on the first day,” Health Minister Harsh Vardhan told his state colleagues on Saturday.

“This vaccine will actually be a ‘sanchivani’ (life-saver) in the fight against the virus,” he added.

The All India Institute of Medical Sciences (AIIMS) in Delhi, the country’s top public hospital, said “there is no information that a security guard has developed an allergy, but there is” no information that he has been admitted to a post-vaccination hospital “. Reaction as soon as his shot is received.

A delegation of doctors at the Ram Manohar Lohia Hospital in New Delhi wrote a letter asking them to replace the coxsackie with the Oxford-AstraZeneca “Covshield” vaccine to eliminate a fear.

“Residents are a little apprehensive about the lack of a thorough test in the case of covax, and should not participate in large numbers to defeat the purpose of the vaccine,” the AFP said in a letter to the hospital’s medical superintendent.

“We urge you to vaccinate us with Covshield, which has completed all phase tests.”

Pathologist Arvind Ahuja shared some concerns with the AFP at the hospital on Saturday.

“I hope it’s good when the data comes out. Ideally, they would have to wait a month and we would be well aware of its effectiveness,” the 45-year-old said.

Vaccine reluctance has emerged as a major concern, with a recent study of 18,000 people across India finding that 69 per cent were in no hurry to get a shot.

Leading scientists and doctors have called on authorities to release performance data on covaxin to boost confidence in the vaccine.

On Saturday, Kovacs’ recipients had to sign an acknowledgment form stating that its “medical effectiveness … has not yet been established.”

Officials said they hoped 300,000 people would be vaccinated on Saturday, but said all potential recipients were not alerted to the shortcomings of the application used to coordinate and monitor the process.

With over 10.5 million corona virus infections and more than 152,000 deaths so far, the world’s second largest known cassette is in India.